Stent thrombosis in a patient receiving chemotherapy

Intravascular stents are successfully used during coronary revascularization. Subacute stent thrombosis is a rare complication, associated with a 40-60% risk of myocardial infarction, and occurs 5-10 days after implantation. We describe a case of late stent thrombosis potentially due to delayed endo...

Full description

Saved in:
Bibliographic Details
Published inCatheterization and cardiovascular diagnosis Vol. 40; no. 4; p. 383
Main Authors Smith, S C, Winters, K J, Lasala, J M
Format Journal Article
LanguageEnglish
Published United States 01.04.1997
Subjects
Angioplasty, Balloon - adverse effects
Antineoplastic Combined Chemotherapy Protocols - adverse effects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Carcinoma, Squamous Cell - complications
Carcinoma, Squamous Cell - drug therapy
Coronary Angiography
Coronary Disease - complications
Coronary Disease - diagnosis
Coronary Disease - therapy
Coronary Thrombosis - diagnosis
Coronary Thrombosis - etiology
Coronary Thrombosis - physiopathology
Equipment Failure
Humans
Lung Neoplasms - complications
Lung Neoplasms - drug therapy
Male
Middle Aged
Stents - adverse effects
Online AccessGet more information

Cover

More Information
Summary:Intravascular stents are successfully used during coronary revascularization. Subacute stent thrombosis is a rare complication, associated with a 40-60% risk of myocardial infarction, and occurs 5-10 days after implantation. We describe a case of late stent thrombosis potentially due to delayed endothelialization from cancer chemotherapy.
ISSN:0098-6569
DOI:10.1002/(SICI)1097-0304(199704)40:4<383::AID-CCD14>3.0.CO;2-O